Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 4 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Breast Neoplasms 9Rectal Neoplasms 3Neoplasm Metastasis 2Colonic Neoplasms 2Upper Gastrointestinal Tumours 1TTP 1Stomach Neoplasms 1Recurrence 1Patient Acceptance of Health Care 1Pancreatic Cancer Non-resectable 1Locally Advanced Colorectal Cancer 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Frailty 1

Interventions

Brentuximab Vedotin 3relmacabtagene autoleucel 2fludarabine phosphate 2fludarabine 2Cytarabine 2Bortezomib 2Antilymphocyte Serum 2xihuang 1tocilizumab 1tislelizumab 1sofosbuvir-velpatasvir drug combination 1sintilimab 1rasburicase 1ledipasvir 1entecavir 1apatinib 1aflibercept 1acalabrutinib 1Urate Oxidase 1Trabectedin 1Thiotepa 1Thalidomide 1Tenofovir 1Tamsulosin 1Sofosbuvir 1Sevoflurane 1Rivaroxaban 1Ribavirin 1Radiotherapy 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Recurrence × Capecitabine × Clear all
NCT06090994 2025-05-07

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Fudan University

Phase 4 Recruiting
756 enrolled
Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡